IVERS-READ GILLIAN C (See Remarks) sold 0.8% of their position (2.33K shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $1.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/3/2022ACC: 0000899243-22-020944
Officer· See Remarks
Since Sep 2018
+7.80K
Net shares
Net buyer
$1.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.12K acquired · 2.33K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.06K
Price / share
—
Trade value
—
% of position
1.8%
6/1/2022
278.78K→283.85K
Common Stock
Direct
Shares
−2.33K
Price / share
$0.64
Trade value
$1.49K
% of position
0.8%
6/2/2022
283.85K→281.52K
Total
Net shares
+2.73K
Net value
-$1.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2022 | M · Option Exercise | +5.06K | — | — | 1.8% | 278.78K | 283.85K |
| Common Stock Direct | 6/2/2022 | S · Sale | −2.33K | $0.64 | $1.49K | 0.8% | 283.85K | 281.52K |
| Total | +2.73K | -$1.49K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5.06K shares
Shares
+5.06K
Strike price
Held after
55.69K
Exercisable
—
6/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.06K shares | 6/1/2022 | M · Option Exercise | +5.06K | — | 55.69K |